Literature DB >> 30314637

Comparative symptom biochemistry between moderate and advanced heart failure.

Christopher S Lee1, Quin E Denfeld2, Bradley E Aouizerat3, Corrine Y Jurgens4, Christopher V Chien5, Emily Aarons6, Jill M Gelow7, Shirin O Hiatt8, James O Mudd9.   

Abstract

BACKGROUND: We have a limited understanding of the biological underpinnings of symptoms in heart failure (HF).
OBJECTIVES: The purpose of this paper was to compare relationships between peripheral biomarkers of HF pathogenesis and physical symptoms between patients with advanced versus moderate HF.
METHODS: This was a two-stage phenotype sampling cohort study wherein we examined patients with advanced HF undergoing ventricular assist device implantation in the first stage, and then patients with moderate HF (matched adults with HF not requiring device implantation) in the second stage. Linear modeling was used to compare relationships among biomarkers and physical symptoms between cohorts.
RESULTS: Worse myocardial stress, systemic inflammation and endothelial dysfunction were associated with worse physical symptoms in moderate HF (n=48), but less physical symptom burden in advanced HF (n=48).
CONCLUSIONS: Where patients are in the HF trajectory needs to be taken into consideration when exploring biological underpinnings of physical HF symptoms.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Biomarkers; Heart failure; Symptoms

Mesh:

Substances:

Year:  2018        PMID: 30314637      PMCID: PMC6530561          DOI: 10.1016/j.hrtlng.2018.09.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  45 in total

1.  Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Authors:  Caroline Kistorp; Jens Faber; Søren Galatius; Finn Gustafsson; Jan Frystyk; Allan Flyvbjerg; Per Hildebrandt
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

2.  Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.

Authors:  Evgenij V Potapov; Felix Hennig; Frank D Wagner; Hans-Dieter Volk; Ralf Sodian; Harald Hausmann; Hans B Lehmkuhl; Roland Hetzer
Journal:  Eur J Cardiothorac Surg       Date:  2005-05       Impact factor: 4.191

3.  Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure.

Authors:  Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Judith M Kramer; Steven Grossman; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Journal:  Eur J Heart Fail       Date:  2002-06       Impact factor: 15.534

Review 4.  Immune activation in chronic heart failure.

Authors:  Guillermo Torre-Amione
Journal:  Am J Cardiol       Date:  2005-06-06       Impact factor: 2.778

5.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Kirkwood F Adams; Gregg C Fonarow; Charles L Emerman; Thierry H LeJemtel; Maria Rosa Costanzo; William T Abraham; Robert L Berkowitz; Marie Galvao; Darlene P Horton
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

6.  Plasma cytokine parameters and mortality in patients with chronic heart failure.

Authors:  M Rauchhaus; W Doehner; D P Francis; C Davos; M Kemp; C Liebenthal; J Niebauer; J Hooper; H D Volk; A J Coats; S D Anker
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

Review 7.  Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications.

Authors:  Pål Aukrust; Lars Gullestad; Thor Ueland; Jan K Damås; Arne Yndestad
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

8.  N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

Authors:  Paulo Bettencourt; Ana Azevedo; Joana Pimenta; Fernando Friões; Susana Ferreira; António Ferreira
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure.

Authors:  Wei-Hsian Yin; Jaw-Wen Chen; Hsu-Lung Jen; Meng-Cheng Chiang; Wen-Pin Huang; An-Ning Feng; Shing-Jong Lin; Mason Shing Young
Journal:  Eur J Heart Fail       Date:  2003-08       Impact factor: 15.534

10.  Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure.

Authors:  Cheryl Hoyt Zambroski; Debra K Moser; Geetha Bhat; Craig Ziegler
Journal:  Eur J Cardiovasc Nurs       Date:  2005-09       Impact factor: 3.908

View more
  2 in total

1.  Identifying unique profiles of perceived dyspnea burden in heart failure.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Karen S Lyons; Jessica Harman Thompson; Christopher S Lee
Journal:  Heart Lung       Date:  2020-05-18       Impact factor: 2.210

2.  Exploring gender differences in trajectories of clinical markers and symptoms after left ventricular assist device implantation.

Authors:  Quin E Denfeld; Kenneth M Faulkner; Mary Roberts Davis; Beth A Habecker; Christopher V Chien; Jill M Gelow; James O Mudd; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2021-10-27       Impact factor: 3.593

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.